Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Tropical Medicine and Gastroenterology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Arab J Gastroenterol. 2022 May;23(2):134-137. doi: 10.1016/j.ajg.2022.01.006. Epub 2022 Feb 10.
The coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, is a new type of acute infectious respiratory syndrome that usually presents with mild flu-like symptoms. However, the disease caused widespread illness and death worldwide, and new sequelae are still being discovered. SARS-CoV-2 RNA was isolated from the fecal samples of some infected patients. Many pathogens, including many viral infections, were linked either to the onset or the exacerbation of inflammatory bowel disease (IBD). With this, we report a series of 2 IBD cases that were diagnosed shortly after recovery from COVID-19. This is the first report that discusses the possibility of developing IBD following COVID-19 infection to the best of our knowledge. This could highlight the importance of thoroughly investigating COVID-19 patients who presented with diarrhea, particularly those with bloody diarrhea, and not consider it a simple manifestation of COVID-19 infection.
新型冠状病毒病（COVID-19）是由新型冠状病毒 SARS-CoV-2 引起的一种新型急性传染性呼吸系统综合征，通常表现为轻度流感样症状。然而，这种疾病在全球范围内造成了广泛的疾病和死亡，新的后遗症仍在被发现。从一些感染患者的粪便样本中分离出了 SARS-CoV-2 RNA。许多病原体，包括许多病毒感染，与炎症性肠病（IBD）的发病或加重有关。在此，我们报告了一系列 2 例 IBD 病例，这些病例在 COVID-19 康复后不久被诊断出来。据我们所知，这是首次报道 COVID-19 感染后可能发生 IBD。这可能强调了彻底调查出现腹泻的 COVID-19 患者的重要性，特别是那些出现血性腹泻的患者，而不应将其简单视为 COVID-19 感染的表现。
